Intas Pharmaceuticals Ltd, which had filed its draft red-herring prospectus (DRHP) with SEBI for a proposed initial public offering (IPO) three months ago to give part exit to existing investor ChrysCapital besides raising some fresh fund, is now rethinking its strategy, sources in the company told VCCircle.The Ahmedabad-based company, one ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.